DrugId:  1
1. Name:  Pyridoxal Phosphate
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  This is the active form of vitamin B6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (pyridoxamine).
4. Indication:  For nutritional supplementation and for treating dietary shortage or imbalance.
DrugId:  2
1. Name:  Aluminum hydroxide
2. Groups:  Approved, Investigational
3. Description:  Aluminum hydroxide is an inorganic salt used as an antacid. It is a basic compound that acts by neutralizing hydrochloric acid in gastric secretions. Subsequent increases in pH may inhibit the action of pepsin. An increase in bicarbonate ions and prostaglandins may also confer cytoprotective effects.
4. Indication:  For relief of heartburn and acid indigestion. 
DrugId:  3
1. Name:  Dihomo-gamma-linolenic acid
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance
DrugId:  4
1. Name:  Amiloride
2. Groups:  Approved
3. Description:  A pyrazine compound inhibiting sodium reabsorption through sodium channels in renal epithelial cells. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with diuretics to spare potassium loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705)
4. Indication:  For use as adjunctive treatment with thiazide diuretics or other kaliuretic-diuretic agents in congestive heart failure or hypertension.
DrugId:  5
1. Name:  Succinic acid
2. Groups:  Approved, Nutraceutical
3. Description:  A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance
DrugId:  6
1. Name:  L-Asparagine
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from aspartic acid and ammonia by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)
4. Indication:  Used for nutritional supplementation, also for treating dietary shortage or imbalance.
DrugId:  7
1. Name:  Creatine
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as creatinine in the urine.
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance.
DrugId:  8
1. Name:  Tetrahydrofolic acid
2. Groups:  Nutraceutical
3. Description:  Tetrahydrofolic acid is a folic acid derivative. It is produced from dihydrofolic acid by dihydrofolate reductase. It is converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. It is a coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids. It acts as a donor of a group with one carbon atom. It gets this carbon atom by sequestering formaldehyde produced in other processes.
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance.
DrugId:  9
1. Name:  Adenine
2. Groups:  Approved, Nutraceutical
3. Description:  A purine base and a fundamental unit of adenine nucleotides.
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance
DrugId:  10
1. Name:  Methazolamide
2. Groups:  Approved
3. Description:  A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma. [PubChem]
4. Indication:  For treatment of chronic open-angle glaucoma and acute angle-closure glaucoma
DrugId:  11
1. Name:  Adenosine monophosphate
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance
DrugId:  12
1. Name:  Gevokizumab
2. Groups:  Investigational
3. Description:  Gevokizumab has been used in trials studying the treatment of Acne Vulgaris, Osteoarthritis, Behcet's Uveitis, Pyoderma Gangrenosum, and Behcet's Disease Uveitis, among others. Gevokizumab acts as a modulator of cytokine imbalance in IL-1 mediated disease states. It has a very high binding affinity of 300fM and blocks the activation of IL-1 receptors.
4. Indication:  Not Available
DrugId:  13
1. Name:  Methyclothiazide
2. Groups:  Approved
3. Description:  A thiazide diuretic with properties similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p825)
4. Indication:  For use in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Also used as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.
DrugId:  14
1. Name:  Alpha-Linolenic Acid
2. Groups:  Approved, Nutraceutical
3. Description:  Alpha-linolenic acid (ALA) is a polyunsaturated omega-3 fatty acid. It is a component of many common vegetable oils and is important to human nutrition.
4. Indication:  For nutritional supplementation and for treating dietary shortage or imbalance.
DrugId:  15
1. Name:  Lipoic Acid
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  A vitamin-like antioxidant.
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance.
DrugId:  16
1. Name:  ATP
2. Groups:  Investigational, Nutraceutical
3. Description:  An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance
DrugId:  17
1. Name:  Pyruvic acid
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance
DrugId:  18
1. Name:  Calcium Carbonate
2. Groups:  Approved, Investigational
3. Description:  Calcium carbonate is an inorganic salt used as an antacid. It is a basic compound that acts by neutralizing hydrochloric acid in gastric secretions. Subsequent increases in pH may inhibit the action of pepsin. An increase in bicarbonate ions and prostaglandins may also confer cytoprotective effects. Calcium carbonate may also be used as a nutritional supplement or to treat hypocalcemia.
4. Indication:  For relief of heartburn and acid indigestion. May also be used as a nutritional supplement or to treat hypocalcemia. 
DrugId:  19
1. Name:  Ornithine
2. Groups:  Approved, Nutraceutical
3. Description:  Ornithine is an amino acid produced in the urea cycle by the splitting off of urea from arginine. It is a central part of the urea cycle, which allows for the disposal of excess nitrogen. L-Ornithine is a precursor of citrulline and arginine.
4. Indication:  Used for nutritional supplementation, also for treating dietary shortage or imbalance. It has been claimed that ornithine improves athletic performance, has anabolic effects, has wound-healing effects, and is immuno-enhancing.
DrugId:  20
1. Name:  Glutathione
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.
4. Indication:  For nutritional supplementation, also for treating dietary shortage or imbalance
DrugId:  21
1. Name:  Romidepsin
2. Groups:  Approved, Investigational
3. Description:  Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) or/and peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior systemic therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not been demonstrated. 
4. Indication:  For the treatment of cutaneous T-cell lymphoma (CTCL) or/and peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior systemic therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not been demonstrated. 
DrugId:  22
1. Name:  Stearic acid
2. Groups:  Approved, Experimental
3. Description:  Stearic acid (IUPAC systematic name: octadecanoic acid) is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is a waxy solid. [Wikipedia]
4. Indication:  Not Available
DrugId:  23
1. Name:  Rifaximin
2. Groups:  Approved, Investigational
3. Description:  Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that the drug will not pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It has multiple indications and is used in treatment of traveller's diarrhea caused by E. coli; reduction in risk of overt hepatic encephalopathy recurrence; as well as diarrhea-predominant irritable bowel syndrome (IBS-D) in adult women and men. It is marketed under the brand name Xifaxan by Salix Pharmaceuticals.
4. Indication:  Rifaximin has multiple indications by the FDA: for the treatment of patients (≥12 years of age) with traveller's diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy recurrence in patients ≥18 years of age; and in May 2015 it was approved for irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women. 
DrugId:  24
1. Name:  L-Glutamine
2. Groups:  Approved, Investigational, Nutraceutical
3. Description:  A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells. An oral formulation of L-glutamine was approved by the FDA in July 2017 for use in sickle cell disease [5]. This oral formulation is marketed under the tradename Endari by Emmaus Medical.
4. Indication:  Used for nutritional supplementation, also for treating dietary shortage or imbalance.Used to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older [FDA Label].
DrugId:  25
1. Name:  3,4-Dihydrouracil
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
